FRMPX
Price
$26.33
Change
+$0.25 (+0.96%)
Updated
Jun 6 closing price
Net Assets
222.07M
VSGIX
Price
$76.52
Change
+$0.78 (+1.03%)
Updated
Jun 6 closing price
Net Assets
34.95B
Interact to see
Advertisement

FRMPX vs VSGIX

Header iconFRMPX vs VSGIX Comparison
Open Charts FRMPX vs VSGIXBanner chart's image
Nuveen Small Cap Growth Opp A
Price$26.33
Change+$0.25 (+0.96%)
VolumeN/A
Net Assets222.07M
Vanguard Small Cap Growth Index I
Price$76.52
Change+$0.78 (+1.03%)
VolumeN/A
Net Assets34.95B
FRMPX vs VSGIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FRMPX vs. VSGIX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FRMPX is a Buy and VSGIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSGIX has more cash in the bank: 35B vs. FRMPX (222M). VSGIX pays higher dividends than FRMPX: VSGIX (0.58) vs FRMPX (0.00). FRMPX was incepted earlier than VSGIX: FRMPX (30 years) vs VSGIX (25 years). FRMPX (1.35) is less costly to investors than VSGIX (0.06). FRMPX is a more actively managed with annual turnover of: 67.00 vs. VSGIX (21.00). FRMPX has a lower initial minimum investment than VSGIX: FRMPX (3000) vs VSGIX (5000000). FRMPX annual gain was more profitable for investors over the last year : 8.71 vs. VSGIX (8.12). VSGIX return over 5 years is better than : 34.06 vs. FRMPX (5.42).
FRMPXVSGIXFRMPX / VSGIX
Total Expense Ratio1.200.062,000%
Annual Report Gross Expense Ratio1.350.062,250%
Fund Existence30 years25 years-
Gain YTD-2.832-3.88073%
Front Load6%N/A-
Min. Initial Investment300050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets222M35B1%
Annual Yield % from dividends0.000.58-
Returns for 1 year8.718.12107%
Returns for 3 years26.4223.03115%
Returns for 5 years5.4234.0616%
Returns for 10 years10.89105.7310%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HY41.260.43
+1.05%
Hyster-Yale Inc.
AKRO54.280.34
+0.63%
Akero Therapeutics
VICI31.470.02
+0.06%
VICI Properties
SGHT4.20N/A
N/A
Sight Sciences
MIGI0.57-0.01
-0.96%
Mawson Infrastructure Group